Compile Data Set for Download or QSAR
Report error Found 23 Enz. Inhib. hit(s) with all data for entry = 8653
TargetNuclear receptor ROR-gamma(Human)
Orca Pharmaceuticals

US Patent
LigandPNGBDBM410768(4-[3-[[2-chloro-6-(trifluoromethyl)phenyl]methyl]i...)
Affinity DataIC50: 19nMAssay Description:The assay was run in black 384 well plates (Greiner cat no: 784900). Various concentrations of test ligands in 0.1 microliters DMSO were dispensed to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Orca Pharmaceuticals

US Patent
LigandPNGBDBM410764(acid | US10383850, Compound 2)
Affinity DataIC50: 71.8nMAssay Description:The assay was run in black 384 well plates (Greiner cat no: 784900). Various concentrations of test ligands in 0.1 microliters DMSO were dispensed to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Orca Pharmaceuticals

US Patent
LigandPNGBDBM410786(4-[3-[[2-chloro-6-(trifluoromethyl)phenyl]methyl]-...)
Affinity DataIC50: 130nMAssay Description:The assay was run in black 384 well plates (Greiner cat no: 784900). Various concentrations of test ligands in 0.1 microliters DMSO were dispensed to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Orca Pharmaceuticals

US Patent
LigandPNGBDBM410784(6-[3-[2-chloro-6-(trifluoromethyl)benzoyl]indazol-...)
Affinity DataIC50: 130nMAssay Description:The assay was run in black 384 well plates (Greiner cat no: 784900). Various concentrations of test ligands in 0.1 microliters DMSO were dispensed to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Orca Pharmaceuticals

US Patent
LigandPNGBDBM410763(US10383850, Compound 1)
Affinity DataIC50: 196nMAssay Description:The assay was run in black 384 well plates (Greiner cat no: 784900). Various concentrations of test ligands in 0.1 microliters DMSO were dispensed to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Orca Pharmaceuticals

US Patent
LigandPNGBDBM410770(US10383850, Compound 8)
Affinity DataIC50: 212nMAssay Description:The assay was run in black 384 well plates (Greiner cat no: 784900). Various concentrations of test ligands in 0.1 microliters DMSO were dispensed to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Orca Pharmaceuticals

US Patent
LigandPNGBDBM410774(US10383850, Compound 12)
Affinity DataIC50: 247nMAssay Description:The assay was run in black 384 well plates (Greiner cat no: 784900). Various concentrations of test ligands in 0.1 microliters DMSO were dispensed to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Orca Pharmaceuticals

US Patent
LigandPNGBDBM410778(6-[3-(2,6-dichlorobenzoyl)indazol-1-yl]pyridine-3-...)
Affinity DataIC50: 250nMAssay Description:The assay was run in black 384 well plates (Greiner cat no: 784900). Various concentrations of test ligands in 0.1 microliters DMSO were dispensed to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Orca Pharmaceuticals

US Patent
LigandPNGBDBM410775(US10383850, Compound 13)
Affinity DataIC50: 373nMAssay Description:The assay was run in black 384 well plates (Greiner cat no: 784900). Various concentrations of test ligands in 0.1 microliters DMSO were dispensed to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Orca Pharmaceuticals

US Patent
LigandPNGBDBM410767(US10383850, Compound 5)
Affinity DataIC50: 380nMAssay Description:The assay was run in black 384 well plates (Greiner cat no: 784900). Various concentrations of test ligands in 0.1 microliters DMSO were dispensed to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Orca Pharmaceuticals

US Patent
LigandPNGBDBM410776(US10383850, Compound 14)
Affinity DataIC50: 514nMAssay Description:The assay was run in black 384 well plates (Greiner cat no: 784900). Various concentrations of test ligands in 0.1 microliters DMSO were dispensed to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Orca Pharmaceuticals

US Patent
LigandPNGBDBM410769(US10383850, Compound 7)
Affinity DataIC50: 575nMAssay Description:The assay was run in black 384 well plates (Greiner cat no: 784900). Various concentrations of test ligands in 0.1 microliters DMSO were dispensed to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Orca Pharmaceuticals

US Patent
LigandPNGBDBM410772(4-[3-(2-fluoro-6-methoxy-benzoyl)indazol-1-yl]benz...)
Affinity DataIC50: 629nMAssay Description:The assay was run in black 384 well plates (Greiner cat no: 784900). Various concentrations of test ligands in 0.1 microliters DMSO were dispensed to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Orca Pharmaceuticals

US Patent
LigandPNGBDBM410780(6-[3-[[2-chloro-6-(trifluoromethyl)phenyl]methyl]-...)
Affinity DataIC50: 630nMAssay Description:The assay was run in black 384 well plates (Greiner cat no: 784900). Various concentrations of test ligands in 0.1 microliters DMSO were dispensed to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Orca Pharmaceuticals

US Patent
LigandPNGBDBM410779(6-[3-[[2-chloro-6-(trifluoromethyl)phenyl]methyl]i...)
Affinity DataIC50: 790nMAssay Description:The assay was run in black 384 well plates (Greiner cat no: 784900). Various concentrations of test ligands in 0.1 microliters DMSO were dispensed to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Orca Pharmaceuticals

US Patent
LigandPNGBDBM410766(4-[3-(2-fluoro-6-methoxy-benzoyl)indol-1-yl]benzoi...)
Affinity DataIC50: 898nMAssay Description:The assay was run in black 384 well plates (Greiner cat no: 784900). Various concentrations of test ligands in 0.1 microliters DMSO were dispensed to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Orca Pharmaceuticals

US Patent
LigandPNGBDBM410781(6-[3-[2-chloro-6-(trifluoromethyl)benzoyl]indol-1-...)
Affinity DataIC50: 1.00E+3nMAssay Description:The assay was run in black 384 well plates (Greiner cat no: 784900). Various concentrations of test ligands in 0.1 microliters DMSO were dispensed to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Orca Pharmaceuticals

US Patent
LigandPNGBDBM410773(US10383850, Compound 11)
Affinity DataIC50: 1.24E+3nMAssay Description:The assay was run in black 384 well plates (Greiner cat no: 784900). Various concentrations of test ligands in 0.1 microliters DMSO were dispensed to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Orca Pharmaceuticals

US Patent
LigandPNGBDBM410782(6-[3-[2-chloro-6-(trifluoromethyl)benzoyl]pyrrolo[...)
Affinity DataIC50: 1.26E+3nMAssay Description:The assay was run in black 384 well plates (Greiner cat no: 784900). Various concentrations of test ligands in 0.1 microliters DMSO were dispensed to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Orca Pharmaceuticals

US Patent
LigandPNGBDBM410771(US10383850, Compound 9)
Affinity DataIC50: 1.35E+3nMAssay Description:The assay was run in black 384 well plates (Greiner cat no: 784900). Various concentrations of test ligands in 0.1 microliters DMSO were dispensed to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Orca Pharmaceuticals

US Patent
LigandPNGBDBM410765(US10383850, Compound 3)
Affinity DataIC50: 1.37E+3nMAssay Description:The assay was run in black 384 well plates (Greiner cat no: 784900). Various concentrations of test ligands in 0.1 microliters DMSO were dispensed to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Orca Pharmaceuticals

US Patent
LigandPNGBDBM410783(5-[3-[2-chloro-6-(trifluoromethyl)benzoyl]indazol-...)
Affinity DataIC50: 1.26E+4nMAssay Description:The assay was run in black 384 well plates (Greiner cat no: 784900). Various concentrations of test ligands in 0.1 microliters DMSO were dispensed to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Orca Pharmaceuticals

US Patent
LigandPNGBDBM410777(5-[3-(2,6-dichlorobenzoyl)indazol-1-yl]pyridine-2-...)
Affinity DataIC50: 1.58E+4nMAssay Description:The assay was run in black 384 well plates (Greiner cat no: 784900). Various concentrations of test ligands in 0.1 microliters DMSO were dispensed to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
Go to US Patent